These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2126915

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Allergen-induced specific and non-specific nasal reactions. Reciprocal relationship and inhibition by topical glucocorticosteroids.
    Andersson M, Andersson P, Pipkorn U.
    Acta Otolaryngol; 1989; 107(3-4):270-7. PubMed ID: 2648750
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Budesonide and nasal allergen challenge testing in man.
    Pipkorn U.
    Allergy; 1982 Feb; 37(2):129-34. PubMed ID: 7137521
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Allergen-induced nasal hyperreactivity appears unrelated to the size of the nasal and dermal immediate allergic reaction.
    Andersson M, von Kogerer B, Andersson P, Pipkorn U.
    Allergy; 1987 Nov; 42(8):631-7. PubMed ID: 3322084
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids.
    Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM.
    N Engl J Med; 1987 Jun 11; 316(24):1506-10. PubMed ID: 2438553
    [Abstract] [Full Text] [Related]

  • 14. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge.
    Hilberg O.
    Allergy; 1995 Aug 11; 50(8):683-8. PubMed ID: 7503405
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticosteroid spray.
    Grønborg H, Bisgaard H, Rømeling F, Mygind N.
    Allergy; 1993 Feb 11; 48(2):87-93. PubMed ID: 8457038
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of orally inhaled budesonide in seasonal allergic rhinitis.
    Greiff L, Andersson M, Svensson C, Linden M, Wollmer P, Brattsand R, Persson CG.
    Eur Respir J; 1998 Jun 11; 11(6):1268-73. PubMed ID: 9657565
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5.
    Linden M, Svensson C, Andersson E, Andersson M, Greiff L, Persson CG.
    Am J Respir Crit Care Med; 2000 Nov 11; 162(5):1705-8. PubMed ID: 11069800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.